Pharyngeal endoscopic submucosal dissection for a pyriform sinus lesion extending beyond the arytenoid to the vocal folds

 

 Permissions and Reprints

Endoscopic submucosal dissection (ESD) is an effective, minimally invasive treatment for superficial pharyngeal cancer (SPC) [1]. However, some cases of pharyngeal ESD are technically difficult because of the complex anatomical features and interference by equipment such as intubation tubes and the laryngoscope. Here, we report a challenging case of pharyngeal ESD for an SPC extending to the vocal folds ([Video 1]).

Video 1 Pharyngeal endoscopic submucosal dissection of a superficial pharyngeal cancer located on the right pyriform sinus that extended beyond the arytenoid and the aryepiglottic fold to the vocal folds side.

An 80-year-old man diagnosed with advanced esophagogastric junction (EGJ) cancer and SPC on the right pyriform sinus was referred to our hospital. Chemotherapy was initiated for treatment of the EGJ lesion and the SPC remained under surveillance. The EGJ lesion was well controlled with chemotherapy for more than 3 years but the pharyngeal lesion increased in size. Therefore, pharyngeal ESD was planned, as any further increase in size may have rendered the lesion untreatable by endoscopic therapy.

The 25-mm pharyngeal lesion on the right pyriform sinus extended beyond the arytenoid and aryepiglottic fold to the vocal folds. The edge of the lesion on the side of the vocal folds could not be observed ([Fig. 1]). Placement of a soft hood (Space Adjuster; TOP Corporation, Tokyo, Japan) on the endoscope enabled us to observe the edge of the lesion on the vocal folds side and to perform the ESD procedure on the side of the vocal folds [2] ([Fig. 2]). After circumferential incision, a ring-shaped thread was applied to provide countertraction [3]. Subepithelial dissection around the right arytenoid was technically difficult because the dissecting layer could not be clearly observed due to fibrosis and rich fatty tissue. We performed dissection carefully with countertraction, and en bloc resection was achieved without adverse events ([Fig. 3]). Histological examination revealed subepithelial invasive squamous cell carcinoma with negative margins ([Fig. 4]).

The patient was extubated immediately after ESD, and was administered intravenous hydrocortisone sodium succinate (50–100 mg/day) for 5 days. He was discharged from hospital 6 days after ESD without adverse events including laryngopharyngeal edema.

Endoscopy_UCTN_Code_CCL_1AB_2AB

Publication History

Article published online:
21 November 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Hanaoka N, Ishihara R, Takeuchi Y. et al. Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video). Gastrointest Endosc 2015; 82: 1002-1008
  CrossrefPubMedGoogle Scholar
• 2 Waki K, Kanesaka T, Ishihara R. et al. A soft hood improves maneuverability in narrow spaces during pharyngeal endoscopic submucosal dissection. Endoscopy 2021; 53: E384-E385
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Matsuno K, Miyamoto H, Tanaka M. Novel traction method for pharyngeal endoscopic submucosal dissection using ring-shaped thread and grasping forceps. Dig Endosc 2020; 32: e120-e121
  CrossrefPubMedGoogle Scholar